{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:31:16Z","timestamp":1791268276515,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"DOI":"10.1007\/s11606-026-10659-1","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:20:42Z","timestamp":1785518442000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Underprescribing of Antifracture Medications Following Non-Traumatic Fracture: A Retrospective Cohort Study"],"prefix":"10.1007","author":[{"given":"William K.","family":"Silverstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget M.","family":"Mayrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Stall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Zipursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5384-275X","authenticated-orcid":false,"given":"Timothy S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"10659_CR1","doi-asserted-by":"publisher","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention and Therapy D. Osteoporosis Prevention, Diagnosis, and Therapy. JAMA. 2001;285(6):785\u2013795. https:\/\/doi.org\/10.1001\/jama.285.6.785.","DOI":"10.1001\/jama.285.6.785"},{"issue":"11","key":"10659_CR2","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/jbmr.2269","volume":"29","author":"NC Wright","year":"2014","unstructured":"Wright NC, Looker AC, Saag KG, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520-2526. https:\/\/doi.org\/10.1002\/jbmr.2269.","journal-title":"J Bone Miner Res."},{"key":"10659_CR3","unstructured":"Papadimitropoulos EA, Coyte PC, Josse RG, Greenwood CE. Current and projected rates of hip fracture in Canada. CMAJ. 1997;157(10):1357\u20131363. https:\/\/pubmed.ncbi.nlm.nih.gov\/9371065."},{"issue":"3","key":"10659_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1359\/jbmr.041133","volume":"20","author":"HX Jiang","year":"2005","unstructured":"Jiang HX, Majumdar SR, Dick DA, et al. Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res. 2005;20(3):494\u2014500. https:\/\/doi.org\/10.1359\/jbmr.041133.","journal-title":"J Bone Miner Res."},{"issue":"2","key":"10659_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004;35(2):375-382. https:\/\/doi.org\/10.1016\/j.bone.2004.03.024.","journal-title":"Bone."},{"key":"10659_CR6","doi-asserted-by":"publisher","unstructured":"Morin SN, Feldman S, Funnell L, et al. Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update. Can Med Assoc J. 2023;195(39):E1333 LP-E1348. https:\/\/doi.org\/10.1503\/cmaj.221647.","DOI":"10.1503\/cmaj.221647"},{"issue":"5","key":"10659_CR7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1595-1622. https:\/\/doi.org\/10.1210\/jc.2019-00221.","journal-title":"Journal of Clinical Endocrinology and Metabolism."},{"issue":"10","key":"10659_CR8","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","volume":"39","author":"F Cosman","year":"2024","unstructured":"Cosman F, Lewiecki EM, Eastell R, et al. Goal-directed osteoporosis treatment: ASBMR\/BHOF task force position statement 2024. J Bone Mineral Res. 2024;39(10):1393-1405. https:\/\/doi.org\/10.1093\/jbmr\/zjae119.","journal-title":"Journal of Bone and Mineral Research."},{"key":"10659_CR9","doi-asserted-by":"publisher","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY, (IOF) on behalf of the SAB of the ES for C and EA of O (ESCEO) and the C of SA and NS of the IOF. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3\u201344. https:\/\/doi.org\/10.1007\/s00198-018-4704-5.","DOI":"10.1007\/s00198-018-4704-5"},{"issue":"5","key":"10659_CR10","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo P, Kapoor E, Asi N, et al. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis. J Clin Endocrinol Metab. 2019;104(5):1623-1630. https:\/\/doi.org\/10.1210\/jc.2019-00192.","journal-title":"J Clin Endocrinol Metab."},{"key":"10659_CR11","doi-asserted-by":"publisher","unstructured":"Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD. Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011. J Bone Mineral Res. 2014;29(9):1929\u20131937. https:\/\/doi.org\/10.1002\/jbmr.2202.","DOI":"10.1002\/jbmr.2202"},{"issue":"7","key":"10659_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1056\/NEJMc2314624","volume":"390","author":"WK Silverstein","year":"2024","unstructured":"Silverstein WK, Cantor N, Cheung AM.\u00a0Postmenopausal Osteoporosis. N Engl J Med. 2024;390(7):673\u2013674","journal-title":"New England Journal of Medicine."},{"issue":"9","key":"10659_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10192","volume":"3","author":"EM Lewiecki","year":"2019","unstructured":"Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J, et al. Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States. JBMR Plus. 2019;3(9):e10192. https:\/\/doi.org\/10.1002\/jbm4.10192.","journal-title":"JBMR Plus."},{"issue":"6","key":"10659_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jval.2017.02.006","volume":"20","author":"T Dunnewind","year":"2017","unstructured":"Dunnewind T, Dvortsin EP, Smeets HM, et al. Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands. Value Health. 2017;20(6):762-768. https:\/\/doi.org\/10.1016\/j.jval.2017.02.006.","journal-title":"Value Health."},{"issue":"7","key":"10659_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/jbmr.2204","volume":"29","author":"SN Morin","year":"2014","unstructured":"Morin SN, Lix LM, Leslie WD. The Importance of Previous Fracture Site on Osteoporosis Diagnosis and Incident Fractures in Women. J Bone Mineral Res. 2014;29(7):1675-1680. https:\/\/doi.org\/10.1002\/jbmr.2204.","journal-title":"Journal of Bone and Mineral Research."},{"issue":"11","key":"10659_CR16","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.1968","volume":"28","author":"D Bliuc","year":"2013","unstructured":"Bliuc D, Nguyen ND, Nguyen TV, Eisman JA, Center JR. Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men. J Bone Miner Res. 2013;28(11):2317-2324. https:\/\/doi.org\/10.1002\/jbmr.1968.","journal-title":"J Bone Miner Res."},{"issue":"11","key":"10659_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S2213-8587(18)30292-4","volume":"6","author":"Endocrinology TLD & Osteoporosis","year":"2018","unstructured":"Endocrinology TLD & Osteoporosis: a roadmap to close the treatment gap. Lancet Diab Endocrinol. 2018;6(11):833. https:\/\/doi.org\/10.1016\/S2213-8587(18)30292-4.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10659_CR18","unstructured":"Ontario Health. Quality Standards: Hip Fracture - Care for People with Fragility Fractures: 2024 Update. 2024."},{"key":"10659_CR19","unstructured":"Office of Disease Prevention and Health Promotion. Osteoporosis Workgroup - Healthy People 2030. 2024. https:\/\/health.gov\/healthypeople\/about\/workgroups\/osteoporosis-workgroup#about."},{"issue":"10","key":"10659_CR20","doi-asserted-by":"publisher","first-page":"e2438393","DOI":"10.1001\/jamanetworkopen.2024.38393","volume":"7","author":"WK Silverstein","year":"2024","unstructured":"Silverstein WK, Wang S, Alavinejad M, et al. Antiosteoporosis Medication Prescriptions After Fragility Fractures. JAMA Netw Open. 2024;7(10):e2438393-e2438393. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.38393.","journal-title":"JAMA Netw Open."},{"issue":"5","key":"10659_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2015.01.014","volume":"128","author":"SC Kim","year":"2015","unstructured":"Kim SC, Kim MS, Sanf\u00e9lix-Gimeno G, et al. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med. 2015;128(5):519-26.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2015.01.014.","journal-title":"Am J Med."},{"issue":"6","key":"10659_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","volume":"156","author":"AA Ghaferi","year":"2021","unstructured":"Ghaferi AA, Schwartz TA, Pawlik TM. STROBE Reporting Guidelines for Observational Studies. JAMA Surg. 2021;156(6):577-578. https:\/\/doi.org\/10.1001\/jamasurg.2021.0528.","journal-title":"JAMA Surg."},{"issue":"2","key":"10659_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/M18-2864","volume":"171","author":"JM Donohue","year":"2019","unstructured":"Donohue JM, Kennedy JN, Seymour CW, et al. Patterns of Opioid Administration Among Opioid-Naive Inpatients and Associations With Postdischarge Opioid Use. Ann Intern Med. 2019;171(2):81-90. https:\/\/doi.org\/10.7326\/M18-2864.","journal-title":"Ann Intern Med."},{"issue":"4","key":"10659_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.7326\/M22-1286","volume":"176","author":"KE Kip","year":"2023","unstructured":"Kip KE, McCreary EK, Collins K, et al. Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19. Ann Intern Med. 2023;176(4):496-504. https:\/\/doi.org\/10.7326\/M22-1286.","journal-title":"Ann Intern Med."},{"issue":"7","key":"10659_CR25","doi-asserted-by":"publisher","first-page":"930","DOI":"10.7326\/ANNALS-24-00775","volume":"178","author":"A Saeed","year":"2025","unstructured":"Saeed A, Mulukutla SR, Thoma F, et al. Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes. Ann Intern Med. 2025;178(7):930-939. https:\/\/doi.org\/10.7326\/ANNALS-24-00775.","journal-title":"Ann Intern Med."},{"issue":"10","key":"10659_CR26","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.18553\/jmcp.2021.27.10.1482","volume":"27","author":"S Blecker","year":"2021","unstructured":"Blecker S, Adhikari S, Zhang H, et al. Validation of EHR medication fill data obtained through electronic linkage with pharmacies. J Manag Care Spec Pharm. 2021;27(10):1482-1487. https:\/\/doi.org\/10.18553\/jmcp.2021.27.10.1482.","journal-title":"J Manag Care Spec Pharm."},{"key":"10659_CR27","doi-asserted-by":"publisher","unstructured":"O\u2019Donnell S, Group CCDSS (CCDSS) OW. Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study. Arch Osteoporos. 2013;8:143. https:\/\/doi.org\/10.1007\/s11657-013-0143-2.","DOI":"10.1007\/s11657-013-0143-2"},{"issue":"10","key":"10659_CR28","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00198-019-05074-8","volume":"30","author":"Y Cui","year":"2019","unstructured":"Cui Y, Lix LM, Yang S, Morin SN, Leslie WD. A population-based study of postfracture care in Manitoba, Canada 2000\/2001\u20132014\/2015. Osteoporos Int. 2019;30(10):2119-2127. https:\/\/doi.org\/10.1007\/s00198-019-05074-8.","journal-title":"Osteoporosis International."},{"issue":"1","key":"10659_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2369-14-81","volume":"14","author":"JL Fleet","year":"2013","unstructured":"Fleet JL, Dixon SN, Shariff SZ, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14(1):81. https:\/\/doi.org\/10.1186\/1471-2369-14-81.","journal-title":"BMC Nephrol."},{"issue":"8","key":"10659_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R, et al. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020;383(8):743-753. https:\/\/doi.org\/10.1056\/NEJMoa1916525.","journal-title":"New England Journal of Medicine."},{"issue":"5","key":"10659_CR31","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00198-011-1630-1","volume":"23","author":"WD Leslie","year":"2012","unstructured":"Leslie WD, Giangregorio LM, Yogendran M, et al. A population-based analysis of the post-fracture care gap 1996\u20132008: the situation is not improving. Osteoporos Int. 2012;23(5):1623-1629. https:\/\/doi.org\/10.1007\/s00198-011-1630-1.","journal-title":"Osteoporosis International."},{"issue":"7","key":"10659_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol. 2004;159(7):702-706. https:\/\/doi.org\/10.1093\/aje\/kwh090.","journal-title":"Am J Epidemiol."},{"key":"10659_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00198-010-1359-2","volume":"22","author":"LA Fraser","year":"2011","unstructured":"Fraser LA, Ioannidis G, Adachi J, et al. Fragility fractures and the osteoporosis care gap in women: The Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2011;22:789-796. https:\/\/doi.org\/10.1007\/s00198-010-1359-2.","journal-title":"Osteoporos Int."},{"issue":"4","key":"10659_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00198-007-0483-0","volume":"19","author":"A Papaioannou","year":"2008","unstructured":"Papaioannou A, Kennedy CC, Ioannidis G, et al. The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2008;19(4):581-587. https:\/\/doi.org\/10.1007\/s00198-007-0483-0.","journal-title":"Osteoporos Int."},{"issue":"12","key":"10659_CR35","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s00198-014-2827-x","volume":"25","author":"A Wilk","year":"2014","unstructured":"Wilk A, Sajjan S, Modi A, Fan CPS, Mavros P. Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA. Osteoporos Int. 2014;25(12):2777-2786. https:\/\/doi.org\/10.1007\/s00198-014-2827-x.","journal-title":"Osteoporosis International."},{"issue":"8","key":"10659_CR36","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00198-020-05358-4","volume":"31","author":"MK Skj\u00f8dt","year":"2020","unstructured":"Skj\u00f8dt MK, Khalid S, Ernst M, et al. Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United\u00a0Kingdom. Osteoporos Int. 2020;31(8):1535-1544. https:\/\/doi.org\/10.1007\/s00198-020-05358-4.","journal-title":"Osteoporosis International."},{"issue":"10","key":"10659_CR37","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00198-021-05890-x","volume":"32","author":"MK Skj\u00f8dt","year":"2021","unstructured":"Skj\u00f8dt MK, Ernst MT, Khalid S, et al. The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications. Osteoporos Int. 2021;32(10):1961-1971. https:\/\/doi.org\/10.1007\/s00198-021-05890-x.","journal-title":"Osteoporosis International."},{"issue":"10","key":"10659_CR38","doi-asserted-by":"publisher","first-page":"e2438393","DOI":"10.1001\/jamanetworkopen.2024.38393","volume":"7","author":"WK Silverstein","year":"2024","unstructured":"Silverstein WK, Wang S, Alavinejad M, et al. Antiosteoporosis Medication Prescriptions After Fragility Fractures. JAMA Netw Open. 2024;7(10):e2438393-e2438393. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.38393.","journal-title":"JAMA Netw Open."},{"key":"10659_CR39","doi-asserted-by":"publisher","unstructured":"Majumdar SR. Quality-improvement interventions for osteoporosis: When are the results worth the effort? CMAJ. 2012;184(3):279 LP - 280. https:\/\/doi.org\/10.1503\/cmaj.111999.","DOI":"10.1503\/cmaj.111999"},{"key":"10659_CR40","doi-asserted-by":"publisher","unstructured":"Rotondi NK, Beaton DE, Sujic R, et al. Identifying and Addressing Barriers to Osteoporosis Treatment Associated with Improved Outcomes: An Observational Cohort Study. J Rheumatol. 2018;45(11):1594 LP - 1601. https:\/\/doi.org\/10.3899\/jrheum.170915.","DOI":"10.3899\/jrheum.170915"},{"key":"10659_CR41","doi-asserted-by":"crossref","unstructured":"Switzer JA, Jaglal S, Bogoch ER. Overcoming Barriers to Osteoporosis Care in Vulnerable Elderly Patients With Hip Fractures. J Orthop Trauma. 2009;23(6). https:\/\/journals.lww.com\/jorthotrauma\/Fulltext\/2009\/07000\/Overcoming_Barriers_to_Osteoporosis_Care_in.13.aspx.","DOI":"10.1097\/BOT.0b013e31815e92d2"},{"issue":"3","key":"10659_CR42","doi-asserted-by":"publisher","first-page":"e180844","DOI":"10.1001\/jamanetworkopen.2018.0844","volume":"1","author":"DC Bauer","year":"2018","unstructured":"Bauer DC. Osteoporosis Treatment After Hip Fracture: Bad News and Getting Worse. JAMA Netw Open. 2018;1(3):e180844-e180844. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0844.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"10659_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13018-019-1103-3","volume":"14","author":"DW Barton","year":"2019","unstructured":"Barton DW, Griffin DC, Carmouche JJ. Orthopedic surgeons\u2019 views on the osteoporosis care gap and potential solutions: survey results. J Orthop Surg Res. 2019;14(1):72. https:\/\/doi.org\/10.1186\/s13018-019-1103-3.","journal-title":"J Orthop Surg Res."},{"key":"10659_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1749-799X-9-45","volume":"9","author":"D Xue","year":"2014","unstructured":"Xue D, Li F, Chen G, Yan S, Pan Z. Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials. J Orthop Surg Res. 2014;9:45. https:\/\/doi.org\/10.1186\/1749-799X-9-45.","journal-title":"J Orthop Surg Res."},{"issue":"4","key":"10659_CR45","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00198-014-3007-8","volume":"26","author":"H Molvik","year":"2015","unstructured":"Molvik H, Khan W. Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporos Int. 2015;26(4):1251-1260. https:\/\/doi.org\/10.1007\/s00198-014-3007-8.","journal-title":"Osteoporosis International."},{"issue":"2","key":"10659_CR46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00198-014-2903-2","volume":"26","author":"YT Li","year":"2015","unstructured":"Li YT, Cai HF, Zhang ZL. Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials. Osteoporos Int. 2015;26(2):431-441. https:\/\/doi.org\/10.1007\/s00198-014-2903-2.","journal-title":"Osteoporosis International."},{"issue":"11","key":"10659_CR47","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s00198-024-07191-5","volume":"35","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Yang Y, Wang J, Meng G. The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials. Osteoporos Int. 2024;35(11):1897-1907. https:\/\/doi.org\/10.1007\/s00198-024-07191-5.","journal-title":"Osteoporosis International."},{"issue":"1","key":"10659_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2213-8587(20)30408-3","volume":"9","author":"Endocrinology TLD & Osteoporosis","year":"2021","unstructured":"Endocrinology TLD & Osteoporosis: overlooked in men for too long. Lancet Diabetes Endocrinol. 2021;9(1):1. https:\/\/doi.org\/10.1016\/S2213-8587(20)30408-3.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"19","key":"10659_CR49","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/archinte.162.19.2217","volume":"162","author":"GM Kiebzak","year":"2002","unstructured":"Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of Osteoporosis in Men With Hip Fracture. Arch Intern Med. 2002;162(19):2217-2222. https:\/\/doi.org\/10.1001\/archinte.162.19.2217.","journal-title":"Arch Intern Med."},{"issue":"9","key":"10659_CR50","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1525-1497.2005.0157.x","volume":"20","author":"RG Miller","year":"2005","unstructured":"Miller RG, Ashar BH, Cohen J, et al. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005;20(9):847-851. https:\/\/doi.org\/10.1111\/j.1525-1497.2005.0157.x.","journal-title":"J Gen Intern Med."},{"issue":"6","key":"10659_CR51","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012;97(6):1802-1822. https:\/\/doi.org\/10.1210\/jc.2011-3045.","journal-title":"J Clin Endocrinol Metab."},{"key":"10659_CR52","doi-asserted-by":"publisher","unstructured":"Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182(17):1864 LP - 1873. https:\/\/doi.org\/10.1503\/cmaj.100771.","DOI":"10.1503\/cmaj.100771"},{"issue":"12","key":"10659_CR53","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1002\/jbmr.2565","volume":"30","author":"S Jha","year":"2015","unstructured":"Jha S, Wang Z, Laucis N, Bhattacharyya T. Trends in Media Reports, Oral Bisphosphonate Prescriptions, and Hip Fractures 1996\u20132012: An Ecological Analysis. J Bone Mineral Res. 2015;30(12):2179-2187. https:\/\/doi.org\/10.1002\/jbmr.2565.","journal-title":"Journal of Bone and Mineral Research."},{"issue":"9","key":"10659_CR54","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/jbmr.3437","volume":"33","author":"S Nayak","year":"2018","unstructured":"Nayak S, Greenspan SL. How Can We Improve Osteoporosis Care? A Systematic Review and Meta-Analysis of the Efficacy of Quality Improvement Strategies for Osteoporosis. J Bone Miner Res. 2018;33(9):1585-1594. https:\/\/doi.org\/10.1002\/jbmr.3437.","journal-title":"J Bone Miner Res."},{"issue":"3","key":"10659_CR55","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00198-020-05308-0","volume":"31","author":"J Martin","year":"2020","unstructured":"Martin J, Viprey M, Castagne B, et al. Interventions to improve osteoporosis care: a systematic review and meta-analysis. Osteoporos Int. 2020;31(3):429-446. https:\/\/doi.org\/10.1007\/s00198-020-05308-0.","journal-title":"Osteoporosis International."},{"issue":"7","key":"10659_CR56","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00198-019-04900-3","volume":"30","author":"H Spechbach","year":"2019","unstructured":"Spechbach H, Fabreguet I, Saule E, et al. Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatients. Osteoporos Int. 2019;30(7):1353-1362. https:\/\/doi.org\/10.1007\/s00198-019-04900-3.","journal-title":"Osteoporosis International."},{"issue":"4","key":"10659_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11914-013-0177-9","volume":"11","author":"JR Curtis","year":"2013","unstructured":"Curtis JR, Silverman SL. Commentary: the five Ws of a Fracture Liaison Service: why, who, what, where, and how? In osteoporosis, we reap what we sow. Curr Osteoporos Rep. 2013;11(4):365-368. https:\/\/doi.org\/10.1007\/s11914-013-0177-9.","journal-title":"Curr Osteoporos Rep."},{"issue":"2","key":"10659_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jbmr.2995","volume":"32","author":"J Leal","year":"2017","unstructured":"Leal J, Gray AM, Hawley S, et al. Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study. J Bone Mineral Res. 2017;32(2):203-211. https:\/\/doi.org\/10.1002\/jbmr.2995.","journal-title":"Journal of Bone and Mineral Research."},{"key":"10659_CR59","unstructured":"International Osteoporosis Foundation. Capture the Fracture. 2024."},{"key":"10659_CR60","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.5972","author":"WK Silverstein","year":"2021","unstructured":"Silverstein WK, Zipursky JS, Shadowitz S. Closing the Osteoporosis Care Gap: A Teachable Moment. JAMA Intern Med. Published online 2021. https:\/\/doi.org\/10.1001\/jamainternmed.2021.5972.","journal-title":"JAMA Intern Med. Published online"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10659-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10659-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:20:44Z","timestamp":1785518444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10659-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":60,"alternative-id":["10659"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10659-1","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":3,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}